Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear

Gerald L Mandell1, Elizabeth J Coleman

  • 1Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA. gm@virginia.edu

Insights

Common fever reducers like ibuprofen and acetaminophen can reduce the effectiveness of antibiotics azithromycin and moxifloxacin by inhibiting their transport and release from immune cells (PMNL). This interaction may compromise therapy efficacy.

Area of Science:

  • Pharmacology
  • Immunology
  • Microbiology

Background:

  • Polymorphonuclear leukocytes (PMNL) are crucial for concentrating, transporting, and releasing antimicrobial agents.
  • Antipyretic agents are commonly co-administered with antimicrobials in febrile patients.
  • The potential impact of antipyretics on antimicrobial delivery by PMNL requires investigation.

Purpose of the Study:

  • To investigate the influence of ibuprofen, acetaminophen, and acetylsalicylic acid on the uptake, transport, and release of azithromycin and moxifloxacin by human PMNL.
  • To assess the clinical implications of co-administering these antipyretics with PMNL-dependent antibiotics.

Main Methods:

  • Quantification of antimicrobial uptake by human PMNL using bioassays of released agents.
  • Assessment of antimicrobial transport and release via chemotactic plates with sentinel bacteria.
  • Evaluation of antipyretic effects on PMNL chemotaxis.

Main Results:

  • Acetylsalicylic acid significantly inhibited azithromycin uptake, while other antipyretics did not.
  • Therapeutic levels of all studied antipyretics inhibited the transport and release of both azithromycin and moxifloxacin by PMNL.
  • PMNL directed and non-directed movement remained unaffected by the antipyretics.

Conclusions:

  • Co-administration of common antipyretics (ibuprofen, acetaminophen, acetylsalicylic acid) with azithromycin or moxifloxacin may compromise antimicrobial therapy efficacy.
  • The inhibition of antimicrobial transport and release by PMNL is a key mechanism for this potential compromise.
  • Clinicians should consider the interaction between antipyretics and PMNL-dependent antibiotics when managing febrile patients.

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...